Display: A A A Contact  | Links
Enabling Clinical and Translational Research

MMI/CAMI Keynote Public Lecture: MRI as a Research Tool, Developments & Directions

Date Posted: 27 Aug 2009

Keynote Public Lecture:
MRI as a Research Tool, Developments & Directions

Dr Martin Graves (University of Cambridge)

Date: 10-11 am, 17 September 2009
Venue: Institute of Molecular Medicine, St James's Hospital, Dublin 8

As part of the MMI/CAMI Workshop:  Magnetic Resonance Imaging Applications in Research, this keynote lecture is open to the public.

Martin Graves is Consultant Clinical Scientist and Head of the MR Physics and Informatics Group at Cambridge University Hospitals NHS Foundation Trust. He has over twenty years' experience in clinical and research MRI in major UK teaching hospitals and has pioneered work in high resolution imaging of atheroma, magnetic resonance fluoroscopy and abdominal MRI in general. He has over 80 peer-reviewed publications and is co-author of the award winning MRI textbook "MRI: from Picture to Proton" and co-editor of “Carotid Disease: The Role of Imaging in Diagnosis and Management”. In 2006 he was a recipient of the International Society of Magnetic Resonance in Medicine (ISMRM) Outstanding Teacher Award and in 2009 was inducted into the GE Healthcare "MR Thought Leader" class. He is very honoured to be giving the MMI/CAMI Keynote Lecture.

Abstract
MRI scanners can produce images with a wide range of signal differences that allow tissues to be discriminated depending upon their physical and biochemical properties. Images can be obtained with high spatial or temporal resolution to investigate both organ morphology and function. MRI scanners can be programmed to display a wide range of physiological phenomena including: cardiac function, blood flow, diffusion, perfusion and neuronal activation. Although MRI has some contraindications, the absence of ionising radiation means that MRI can be used to study both healthy volunteers and allows serial imaging in patients. Through the use of novel contrast agents MRI is beginning to target cellular and molecular processes. Continuing technical development is establishing MRI as the ‘gold-standard’ for many clinical and research studies


This lecture is open to all and there is no need to apply for this unless you wish to attend the whole workshop. Please click
here for further details and how to apply for the half-day Workshop